Ameze Simbo

Ameze Simbo


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 February 2024 in Journal of Public Health
Verified
Journal Article
Open access
PDF file
DDD Duval
D Duval
BEB Evans
B Evans
ASA Sanders
A Sanders
JHJ Hill
J Hill
ASAmeze Simbo
Ameze Simbo
IOI Oliver
I Oliver
Background: Non-pharmaceutical interventions (NPIs) were crucial in the response to the COVID-19 pandemic, although uncertainties about their effectiveness remain. This work aimed to better understand the evidence generated during the pandemic on the effectiveness of NPIs implemented in the UK. Methods: We conducted a rapid mapping review (search date: 1 March 2023) to identify primary studies reporting on the effectiveness of NPIs to reduce COVID-19 transmission. Included studies were displayed in an interactive evidence gap map. Results: After removal of duplicates, 11 752 records were screened. Of these, 151 were included, including 100 modelling studies but only 2 randomized controlled trials and 10 longitudinal observational studies. Most studies reported on NPIs to identify and isolate those who are or may become infectious, and on NPIs to reduce the number of contacts. There was an evidence gap for hand and respiratory hygiene, ventilation and cleaning. Conclusions: Our findings show that despite the large number of studies published, there is still a lack of robust evaluations of the NPIs implemented in the UK. There is a need to build evaluation into the design and implementation of public health interventions and policies from the start of any future pandemic or other public health emergency.

14 August 2019 in European Respiratory Journal
Verified
Journal Article
Closed access
JDJane C. Davies
Jane C. Davies
EAEric Alton
Eric Alton
ASAmeze Simbo
Ameze Simbo
RMRonan Murphy
Ronan Murphy
ISIshani Seth
Ishani Seth
CGClaire Guest
Claire Guest

30 September 2021 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
JMJim McLauchlin
Jim McLauchlin
HAH. Aird
H. Aird
CAC. Amar
C. Amar
GBG. Boyd
G. Boyd
ABA. Brindle
A. Brindle
MSM. Swindlehurst
M. Swindlehurst
A case of listeriosis occurred in a hospitalised patient in England in July 2017. Analysis by whole genome sequencing of the Listeria monocytogenes from the patient's blood culture was identified as clonal complex (CC) 121. This culture was indistinguishable to isolates from sandwiches, salads and the maufacturing environment of Company X which supplied these products widely to the National Health Service. Whilst an inpatient, the case was served sandwiches produced by this company on 12 occasions. No other cases infected by this type were detected in the UK between 2016 and 2020. Between 2016 and 2020, more than 3000 samples of food, food ingredients and environmental swabs from this company were tested. Listeria monocytogenes contamination rates declined after July 2017 from 31% to 0.3% for salads and 3% to 0% for sandwiches. A monophyletic group of 127 L. monocytogenes CC121 isolates was recovered during 2016–2019 and was used to estimate the time of the most recent common ancestor as 2014 (95% CI of between 2012 and 2016). These results represent persistent contamination of equipment, food contact surfaces and foods at a food manufacturer by a single L. monocytogenes strain. Colonisation and persistent contamination of food and production environments are risks for public health.